Search
for
Sort by
Research 31–60 of 73
- Hair Changes due to Drugs
- Poster Abstracts
- A Case of Gynecomastia Induced by Use of Doxazosin
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
- Comparative Chemical Profiling and Monacolins Quantification in Red Yeast Rice Dietary Supplements by 1H-NMR and UHPLC-DAD-MS
- Agglomerative clustering-based drugs graded for the risk signals of drug-induced cognitive disorder: a study on the FAERS database
- Effects of GLP ‐1 Receptor Agonists on Hair Loss and Regrowth: A Systematic Review
- BH02 (P100) Critically appraised topic: is dupilumab a cause or a treatment for alopecia areata? A case series and literature review to guide discussions in clinical practice
- P100 Critically appraised topic: is dupilumab a cause or a treatment for alopecia areata? A case series and literature review to guide discussions in clinical practice
- Culprits of Medication-Induced Telogen Effluvium, Part 2
- Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
- Trichohyalin is a Potential Major Autoantigen in Human Alopecia Areata
- Risks and side effects in the medical management of benign prostatic hyperplasia
- Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network
- Association of Spironolactone Use With Risk of Cancer
- A Gender Hypothesis of sex disparities in adverse drug events
- Impact of Medical Castration on Malignant Arrhythmias in Patients With Prostate Cancer
- Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long‐Term Multicentre Real‐World Study
- Short-Term Side Effects of Low Dose Valproate Monotherapy in Epileptic Children: A Prospective Study.
- The post-finasteride syndrome: possible etiological mechanisms and symptoms
- Antiseizure Medication-Induced Alopecia: A Literature Review
- Suspected adverse reactions to medications and food supplements containing <i>Serenoa repens</i>: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports
- Drug-induced vitiligo: a real-world pharmacovigilance analysis of the FAERS database
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Advances in hair growth
- Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance
- Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases